about
Levamisole for chronic hepatitis BFinally sofosbuvir: an oral anti-HCV drug with wide performance capabilityOutcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantationImmuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexusMicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapyClinical significance of "anti-HBc alone" in human immunodeficiency virus-positive patientsHigh levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treaEnhancing our understanding of current therapies for hepatitis C virus (HCV)Comparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border regionCharacterization of treatment-naive HIV/HBV co-infected patients attending ART clinic of a tertiary healthcare centre in eastern IndiaHepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infectionHIV-, HCV-, and co-infections and associated risk factors among drug users in southwestern China: a township-level ecological study incorporating spatial regressionMELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates.Co-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlatesEfficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues: A Prospective Study.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerHepatitis B virus infection in a cohort of HIV infected blood donors and AIDS patients in Sichuan, China.Predicting the outcomes of combination therapy in patients with chronic hepatitis C using artificial neural network.A nucleic-acid hydrolyzing single chain antibody confers resistance to DNA virus infection in hela cells and C57BL/6 miceTreatment of hepatitis C virus infection with interferon and small molecule direct antivirals: viral kinetics and modelingScreening for hepatitis C among HIV positive patients at Mulago hospital in Uganda.The hepatitis C cascade of care among HIV infected patients: a call to address ongoing barriers to care.Hepatitis C treatment: current and future perspectivesGuidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theMonocyte activation in HIV/HCV coinfection correlates with cognitive impairment.Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy.Transcriptomic assay of CD8+ T cells in treatment-naïve HIV, HCV-mono-infected and HIV/HCV-co-infected Chinese.HIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFkappaBThe impact of HBV or HCV infection in a cohort of HIV-infected pregnant women receiving a nevirapine-based antiretroviral regimen in Malawi.HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologiesLiver transplantation in HCV/HIV positive patients.Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection.HIV through the looking glass: insights derived from Hepatitis BPrevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya.Effects of host and virus related factors on interferon-α+ribavirin and pegylated-interferon+ribavirin treatment outcomes in chronic Hepatitis C patients.A reliable multiplex genotyping assay for HCV using a suspension bead array.HCV and HIV co-infection: mechanisms and management.The geographic distribution patterns of HIV-, HCV- and co-infections among drug users in a national methadone maintenance treatment program in Southwest China.Coinfection with HIV-1 and HCV--a one-two punch.Hepatic HMOX1 expression positively correlates with Bach-1 and miR-122 in patients with HCV mono and HIV/HCV coinfection
P2860
Q24236771-EC46F53A-9ACD-449D-8A57-7A6F1FE037F9Q26822400-CA804F52-7960-467B-8778-AA04744FF636Q26864478-8D186478-371E-4FF3-AABA-5565F1E58EC7Q26991958-6827A087-ECF5-4227-9A9E-25754EC92CA3Q27015778-E0E3A3ED-4D65-4850-AA2B-47D674005369Q27488236-FED0D3CF-DB91-428E-97BF-5D436605DAF2Q27490328-D8C5ECD4-95A9-46C4-AD20-C43FA236F042Q28085718-D0E3DAD7-F9D9-4C46-AE9F-A64D1E3B001CQ28476802-6F50081D-19BA-4BEC-8EC1-2EF96C839D97Q28536346-6A4D7AD4-3250-4B34-84D4-A2E2B94FF05DQ28537754-F713EF7C-5458-4931-9591-24F43771F213Q28541708-00DBA9F2-593A-4125-9EBC-FC9B82E996C8Q30433644-DC3C5269-6921-4CE8-B6A6-2E1BCECA7930Q33576933-AD0978A8-BF9C-448A-9165-44CFFB88D247Q33608997-0C7EC7E1-7400-4450-A718-ECB65EAB3F76Q33650105-62447F2B-46A7-42B5-9383-895496AB5AC6Q33794433-E80EE14F-7A96-4B88-B251-4C2B141C7E3AQ33808119-52A585CA-F1A9-4B29-8B73-4CCEC5ECCA07Q33812764-03F7425E-B326-4753-84FA-9FC7C84C0BA4Q33899320-9E3CB1DF-7094-4346-B37B-DE51FC696ED5Q33918653-2E8E25EB-228C-4AC9-8677-F7F2DF3AADEBQ33921543-F4D2BD53-21A3-486A-BCFC-932317D18CAFQ34147323-DE53BEF3-6BE8-40CA-9331-8B3B1970621FQ34212799-77EE2234-3CF4-4A5F-AE7E-55A699A0A75DQ34329530-A75C3BA4-CFA3-4A80-A2B6-BFE0A8471537Q34417838-737CAABA-B6F4-47E7-941D-2330BF682E18Q34428339-03D8F5AF-2BA7-47B8-B70D-E51CCF97FAB7Q34509401-AFEA05FC-3156-4DB1-BEFD-EA082836B6B3Q34523530-8AFB6277-994B-4B62-BF52-31EFEEB8C7F6Q34561257-05D96F98-EA6D-4BE8-948D-1C473DB22A3EQ34640985-9934C038-9D8E-40C1-BC8D-A7B347221492Q34648954-A624EBC5-3C4C-4B47-80DF-8714BFF812C2Q34977407-D6986528-D6D5-4225-A7E8-4AD8D2A64C3AQ34982182-A7A0526F-A87A-4E18-9768-D3136A2EF9A6Q35040102-70FF1EC4-ED74-4B53-8D33-793B727809C5Q35062971-76E5F292-2C5C-4EF4-86C7-59B395C47BC0Q35090634-7129EB14-4494-4E21-8AE7-5019D8B1209DQ35115722-62C53303-BA8E-4031-BAC6-892A49EE7A08Q35137038-062D6453-8E38-4959-BDB3-25D6DFD5A87FQ35154024-93C852AF-3D41-42F3-9B5B-AC1DA5A9B27A
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Viral hepatitis in HIV infection.
@ast
Viral hepatitis in HIV infection.
@en
Viral hepatitis in HIV infection.
@nl
type
label
Viral hepatitis in HIV infection.
@ast
Viral hepatitis in HIV infection.
@en
Viral hepatitis in HIV infection.
@nl
prefLabel
Viral hepatitis in HIV infection.
@ast
Viral hepatitis in HIV infection.
@en
Viral hepatitis in HIV infection.
@nl
P2860
P356
P1476
Viral hepatitis in HIV infection.
@en
P2093
Margaret James Koziel
Marion G Peters
P2860
P304
P356
10.1056/NEJMRA065142
P407
P577
2007-04-01T00:00:00Z